| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3cc7ff91c24c0e3fee894ad6bede470
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ee75ce2f486c601ad16453fb208985a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b58f981963f6d55d627139e778c4ef7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46ee07796602ee5b5f93a48cf4d9092e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_301a2fa4f19a3f4579333f14d2a03151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a072a405eda6f0b5501def378a07c2f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-145 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_957a11b5f13cc8c7147e0b2d81a91565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd40ad1bb819cd5c66e4ad024aeb2d13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470e80c20404a70b04fb5e8b16d89aa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48b72f649afd7eab150f7b8290a40285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a62e23b8fdf581143cb864ae029d907 |
| publicationDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004011486-A8 |
| titleOfInvention |
Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| abstract |
The invention concerns a molecule of pharmaceutical interest, preferably a hydrophobic major histocompatibility complex (MHC) ligand soluble in solvents such as DMSO, solubilized in an aqueous medium capable of being injected into a human being for preparing a pharmaceutical composition designed to induce an immune response mediated by cytotoxic T lymphocytes. The invention also concerns the use of such peptides mixed or coupled with a carrier protein for preparing a vaccine composition for preventing infectious diseases or for treating cancers. The invention further concerns said peptides, in particular as anti-infectious or antitumoral medicine. |
| priorityDate |
2002-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |